Success story : Biomunex Pharmaceuticals

January 2024

A few months ago, in one of the last DYSL Pierre-Emmanuel Gerard, presented the key issues of BIOMUNEX PHARMACEUTICALS.

Very happy to share today this excellente news for the development of #Biomunex.

For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.

Congratulations to the entire team for starting this clinical study ! 👏

Find out more👉

#Partnership #innovation #biotech #healthcare #immunotherapy #XIR